Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
D Hagin, T Freund, M Navon, T Halperin, D Adir… - Journal of Allergy and …, 2021 - Elsevier
Background In mid-December 2020, Israel started a nationwide mass vaccination campaign
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel, …
against coronavirus disease 2019 (COVID-19). In the first few weeks, medical personnel, …
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
…, I Boudhabhay, H Baris-Feldman, D Hagin… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …
Haploidentical hematopoietic transplantation: current status and future perspectives
Y Reisner, D Hagin, MF Martelli - Blood, The Journal of the …, 2011 - ashpublications.org
For patients with hematologic malignancies at high risk of relapse who do not have matched
donors, a suitable alternative stem cell source is the HLAhaploidentical 2 or 3-loci …
donors, a suitable alternative stem cell source is the HLAhaploidentical 2 or 3-loci …
[PDF][PDF] A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection
SARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from silent
infection to lethal disease. The role of human genetics in determining clinical response to …
infection to lethal disease. The role of human genetics in determining clinical response to …
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
…, H Baris-Feldman, D Hagin… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …
[HTML][HTML] Safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients after allogeneic HCT or CD19-based CART therapy—a single-center …
R Ram, D Hagin, N Kikozashvilli, T Freund… - … and cellular therapy, 2021 - Elsevier
Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA
COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated …
COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated …
Hematopoietic stem cell transplantation for CTLA4 deficiency
…, Z Nademi, S Skoda-Smith, D Hagin… - Journal of Allergy and …, 2016 - jacionline.org
The diagnosis was made retrospectively in 7 patients who underwent HSCT for life-threatening,
treatment-resistant immune dysregulation and in 1 patient prospectively. Clinical and …
treatment-resistant immune dysregulation and in 1 patient prospectively. Clinical and …
[HTML][HTML] Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked …
E Gambineri, S Ciullini Mannurita, D Hagin… - Frontiers in …, 2018 - frontiersin.org
Background: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX)
Syndrome is a rare recessive disorder caused by mutations in the FOXP3 gene. In addition, …
Syndrome is a rare recessive disorder caused by mutations in the FOXP3 gene. In addition, …
Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome
N Hubbard, D Hagin, K Sommer, Y Song… - Blood, The Journal …, 2016 - ashpublications.org
Loss of CD40 ligand (CD40L) expression or function results in X-linked hyper-immunoglobulin
(Ig)M syndrome (X-HIGM), characterized by recurrent infections due to impaired …
(Ig)M syndrome (X-HIGM), characterized by recurrent infections due to impaired …
[HTML][HTML] The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1
…, R Kobbe, S Borte, M Borte, DA Wright, D Hagin… - Journal of clinical …, 2016 - Springer
Purpose Gain-of-function (GOF) mutations in the signal transducer and activator of transcription
1 (STAT1) result in unbalanced STAT signaling and cause immune dysregulation and …
1 (STAT1) result in unbalanced STAT signaling and cause immune dysregulation and …
